Panagora Asset Management Inc Eli Lilly & CO Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Panagora Asset Management Inc holds 117,372 shares of LLY stock, worth $93.5 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

117,372

Previous 210,812 44.32%

Holding current value

$93.5 Million

Previous $191 Million 45.52%

% of portfolio

0.51%

Previous 0.97%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $72.1 Million - $89.7 Million	-93,440 Reduced 44.32%	117,372 $104 Million
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $1.38 Million - $1.73 Million	1,898 Added 0.91%	210,812 $191 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $17.7 Million - $23.7 Million	29,882 Added 16.69%	208,914 $163 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $34.3 Million - $40.5 Million	-65,379 Reduced 26.75%	179,032 $104 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $19.9 Million - $27.4 Million	45,664 Added 22.98%	244,411 $131 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $32.6 Million - $43.6 Million	92,909 Added 87.78%	198,747 $93.2 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $10.4 Million - $12.2 Million	-33,357 Reduced 23.96%	105,838 $36.3 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $1.46 Million - $1.7 Million	4,535 Added 3.37%	139,195 $50.9 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.31 Million - $1.49 Million	4,407 Added 3.38%	134,660 $43.5 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $773,475 - $908,174	-2,775 Reduced 2.09%	130,253 $42.2 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $9.69 Million - $12 Million	41,309 Added 45.04%	133,028 $38.1 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $2.89 Million - $3.59 Million	12,859 Added 16.31%	91,719 $25.3 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $901,912 - $1.11 Million	-4,070 Reduced 4.91%	78,860 $18.2 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $6.64 Million - $8.58 Million	-36,758 Reduced 30.71%	82,930 $19 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $16.2 Million - $20.9 Million	-98,381 Reduced 45.11%	119,688 $22.4 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $2.47 Million - $3.27 Million	18,938 Added 9.51%	218,069 $36.8 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $4.83 Million - $5.59 Million	33,027 Added 19.88%	199,131 $29.5 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $11.7 Million - $14 Million	85,540 Added 106.18%	166,104 $27.3 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $20.5 Million - $25.4 Million	-172,484 Reduced 68.16%	80,564 $11.2 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $21.8 Million - $27 Million	-203,947 Reduced 44.63%	253,048 $33.3 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $532,988 - $579,754	-4,991 Reduced 1.08%	456,995 $51.1 Million
Q2 2019 Aug 09, 2019	BUY	$110.79 - $129.32 $29.2 Million - $34.1 Million	263,693 Added 132.98%	461,986 $51.2 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $8.04 Million - $9.46 Million	72,239 Added 57.31%	198,293 $25.7 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $639,106 - $715,992	6,035 Added 5.03%	126,054 $14.6 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $599,045 - $748,701	-6,977 Reduced 5.49%	120,019 $12.9 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $5.19 Million - $5.95 Million	68,517 Added 117.17%	126,996 $10.8 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $15.3 Million - $18.1 Million	-206,496 Reduced 77.93%	58,479 $4.53 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $39 Million - $41.9 Million	-476,290 Reduced 64.25%	264,975 $22.4 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $57.1 Million - $63.4 Million	741,265	741,265 $63.4 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Eli Lilly & CO Transaction History